300439.SZ SHZ
Medicalsystem Biotechnology Co., Ltd.
1W: +1.7%
1M: +7.7%
3M: +22.8%
YTD: -1.0%
1Y: -13.0%
3Y: -5.9%
5Y: -45.6%
¥10.25 ($1.53)
+0.11 (+1.08%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$398M
-37.2% ▼
5Y CAGR: -7.9%
Capital Expenditures
$421M
-50.0% ▼
5Y CAGR: +3.0%
Free Cash Flow
-$23M
-106.4% ▼
Dividends Paid
$52M
-5.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$226M
-234.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $294M | $190M | $205M | $259M | $263M |
| Depreciation & Amort. | $174M | $195M | $192M | $170M | $210M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $496M | $19M | $72M | $186M | -$71M |
| Other Non-Cash Items | -$51M | $112M | $96M | $18M | -$4M |
| Operating Cash Flow | $912M | $515M | $565M | $634M | $398M |
| — Investing Activities — | |||||
| Capital Expenditures | -$383M | -$202M | -$303M | -$280M | -$421M |
| Acquisitions (Net) | $13M | $5M | $34M | $64M | $24M |
| Investment Purchases | $26M | -$301M | -$280M | -$273M | -$1.1B |
| Investment Sales | $74M | $277M | $309M | $321M | $939M |
| Other Investing | $16M | $33M | $9M | -$32M | $49M |
| Investing Cash Flow | -$253M | -$188M | -$232M | -$201M | -$527M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$575M | -$477M | -$149M | -$228M | -$27M |
| Stock Repurchased | -$28M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$125M | -$60M | -$36M | -$50M | -$52M |
| Other Financing | -$45M | $592M | -$21M | -$16M | -$17M |
| Financing Cash Flow | -$774M | $24M | -$221M | -$294M | -$96M |
| Net Change in Cash | -$115M | $353M | $110M | $168M | -$226M |
| Cash End of Period | $321M | $674M | $784M | $952M | $727M |
| Free Cash Flow | $529M | $314M | $262M | $353M | -$23M |